Brand Name: RABCOP-I
Generic Name: Rabeprazole Sodium BP and Itopride Hydrochloride
Available Strengths:
Rabeprazole Sodium BP 20mg ((as Sustain Release pellets) Domperidone BP 30 mg (as Sustain Release pellets)
Rabeprazole & Itopride Capsules are a fixed-dose combination formulated to manage acid-related gastrointestinal disorders and impaired gastric motility. Rabeprazole, a proton pump inhibitor, reduces gastric acid secretion, promoting healing of the stomach and esophagus, while Itopride enhances gastric emptying and alleviates symptoms such as bloating, nausea, postprandial fullness, and dyspepsia. This combination ensures rapid, long-lasting relief from gastroesophageal reflux disease (GERD), functional dyspepsia, and related upper gastrointestinal discomforts. Manufactured under strict quality standards, these capsules provide consistent therapeutic efficacy and safety. They should be taken strictly under medical supervision for optimal results.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com